MannKind Corp (MNKD)
7.09
-0.08
(-1.12%)
USD |
NASDAQ |
Nov 04, 16:00
7.12
+0.03
(+0.42%)
After-Hours: 20:00
MannKind Profit Margin (Quarterly): -2.78% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -2.78% |
March 31, 2024 | 16.04% |
December 31, 2023 | 2.40% |
September 30, 2023 | 3.36% |
June 30, 2023 | -10.83% |
March 31, 2023 | -24.11% |
December 31, 2022 | -49.77% |
September 30, 2022 | -43.97% |
June 30, 2022 | -153.6% |
March 31, 2022 | -216.8% |
December 31, 2021 | -224.2% |
September 30, 2021 | -19.93% |
June 30, 2021 | -152.6% |
March 31, 2021 | -74.08% |
December 31, 2020 | -143.2% |
September 30, 2020 | -73.31% |
June 30, 2020 | -67.83% |
March 31, 2020 | -57.42% |
December 31, 2019 | -89.18% |
September 30, 2019 | -71.05% |
June 30, 2019 | -82.57% |
March 31, 2019 | -85.30% |
December 31, 2018 | -60.82% |
September 30, 2018 | -540.8% |
June 30, 2018 | -582.5% |
Date | Value |
---|---|
March 31, 2018 | -876.9% |
December 31, 2017 | -723.7% |
September 30, 2017 | -1.61K% |
June 30, 2017 | -1.63K% |
March 31, 2017 | -542.5% |
December 31, 2016 | |
September 30, 2016 | 77.93% |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | -122.4K% |
June 30, 2012 | |
March 31, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-224.2%
Minimum
Dec 2021
16.04%
Maximum
Mar 2024
-72.73%
Average
-57.42%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
Mirum Pharmaceuticals Inc | -31.64% |
NovaBay Pharmaceuticals Inc | -66.04% |
Palatin Technologies Inc | -2.36K% |
iBio Inc | -4.44K% |
Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | 2.89% |
Return on Invested Capital | 62.50% |
Gross Profit Margin (Quarterly) | 71.85% |
Operating Margin (Quarterly) | 22.22% |
Return on Net Operating Assets | 8.92% |